World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
33428
World Ranking
10467
National Ranking
5385

James J. Leyden publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James J. Leyden sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 407 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James J. Leyden D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James J. Leyden sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

James J. Leyden is affiliated with the University of Pennsylvania in the United States. Their research predominantly focuses on medicine, with a substantial emphasis on dermatology, as evidenced by 29 publications in this subfield. Other areas of study include epidemiology, genetics, pathology and forensic medicine, and surgery.

Their work covers several main topics such as acne and rosacea treatments and effects, skin protection and aging, dermatology and skin diseases, autoimmune and inflammatory disorders, nail diseases and treatments, autoimmune bullous skin diseases, and the medical and dermatological studies history.

Frequent coauthors in their research include John S. Barbieri, Ramie Fathy, Brian Chu, Robert G. Micheletti, and Misha Rosenbach.

They have published extensively in notable venues, with a particular concentration in the Journal of the American Academy of Dermatology. Other frequent publication venues include the International Journal of Women's Dermatology, JAMA Dermatology, Journal of Clinical Investigation, and International Journal of Dermatology.

  • COVID-19 and personal protective equipment: Treatment and prevention of skin conditions related to the occupational use of personal protective equipment (2020) - Journal of the American Academy of Dermatology
  • Long-term use of spironolactone for acne in women: A case series of 403 patients (2021) - Journal of the American Academy of Dermatology
  • Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome (2022) - Journal of Clinical Investigation
  • Skin of color representation in dermatology atlases (2022) - Journal of the American Academy of Dermatology
  • Acne and antibiotics: a look back (2021) - International Journal of Dermatology

Best Publications

  • Guidelines of care for the management of acne vulgaris

    Andrea L. Zaenglein;Arun L. Pathy;Bethanee J. Schlosser;Ali Alikhan

  • Management of Acne: A Report From a Global Alliance to Improve Outcomes in Acne

    Harald Gollnick;William Cunliffe;Diane Berson;Brigitte Dreno

  • New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group

    Diane Thiboutot;Harald Gollnick;Vincenzo Bettoli;Brigitte Dréno

  • Staphylococcus aureus in the lesions of atopic dermatitis

    James J. Leyden;Richard R. Marples;Albert M. Kligman

  • A Randomized, Double-Blind, Multicenter Comparison of the Efficacy and Tolerability of Restylane Versus Zyplast for the Correction of Nasolabial Folds

    Rhoda S. Narins;Fredric Brandt;James Leyden;Z. Paul Lorenc

  • Topical tretinoin for photoaged skin

    Albert M. Kligman;Gary L. Grove;Ryoji Hirose;James J. Leyden

  • Guidelines of care for acne vulgaris management.

    John S. Strauss;Daniel P. Krowchuk;James J. Leyden;Anne W. Lucky

  • Photoaging/photodamage and photoprotection.

    Charles R. Taylor;Robert S. Stern;James J. Leyden;Barbara A. Gilchrest

  • The Microbiology of the Human Axilla and Its Relationship to Axillary Odor

    James J. Leyden;Kenneth J. McGinley;Erhard Hölzle;John N. Labows

  • Analyses of volatile organic compounds from human skin.

    M. Gallagher;C.J. Wysocki;J.J. Leyden;A.I. Spielman

  • New insights into rosacea pathophysiology: A review of recent findings

    Martin Steinhoff;Jürgen Schauber;James J. Leyden

  • Safety of doxycycline and minocycline: a systematic review.

    Kelly Smith;James J. Leyden

  • HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum

    Román Pérez-Soler;Jean Pierre Delord;Allan Halpern;Karen Kelly

  • Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne

    Diane M. Thiboutot;Brigitte Dréno;Abdullah Abanmi;Andrew F. Alexis

  • Propionibacterium levels in patients with and without acne vulgaris.

    James J. Leyden;Kenneth J. McGinley;Otto H. Mills;Albert M. Kligman

  • Therapy for Acne Vulgaris

    James J. Leyden

  • A review of the use of combination therapies for the treatment of acne vulgaris

    James J Leyden

  • Propionibacterium acnes resistance to antibiotics in acne patients

    James J. Leyden;Kenneth J. McGinley;Stephen Cavalieri;Guy F. Webster

  • Finasteride in the treatment of men with frontal male pattern hair loss.

    J. Leyden;F. Dunlap;B. Miller;P. Winters

  • Quantitative Microbiology of the Scalp in Non-Dandruff, Dandruff, and Seborrheic Dermatitis

    Kenneth J McGinley;James J Leyden;Richard R Marples;M.R.C. Path

Frequent Co-Authors

Albert M. Kligman
Albert M. Kligman University of Pennsylvania
Lawrence F. Eichenfield
Lawrence F. Eichenfield University of California, San Diego
Harald Gollnick
Harald Gollnick Otto-von-Guericke University Magdeburg
Elaine Larson
Elaine Larson Columbia University
Robert M. Lavker
Robert M. Lavker Northwestern University
Brigitte Dreno
Brigitte Dreno University of Nantes
Gerald G. Krueger
Gerald G. Krueger University of Utah
David J. Margolis
David J. Margolis University of Pennsylvania
William J. Cunliffe
William J. Cunliffe University of Leeds
George H. Talbot
George H. Talbot Sanofi (France)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers outside traditional MD paths, a variety of related online degrees offer flexible options to enter healthcare. If pharmacy appeals to you, many students explore online pharmacy schools. These programs provide advanced pharmaceutical education with the convenience of remote learning.

Technology plays a growing role in healthcare, making a health information management degree online highly relevant. This career path helps you build skills in data security, patient records, and information systems.

For those looking for quick entry into the field, medical coding is a strong option. Understanding how much does it cost to become a medical coder is important, as expenses are generally lower and programs can be completed in less time.

Additionally, students who wish to advance in nursing should consider the cheapest fnp programs online. Becoming a Family Nurse Practitioner opens doors to primary care roles and a wide range of employment opportunities.

Best Scientists Citing James J. Leyden

Trending Scientists

Recently Published Articles